(MedPage Today) — A higher and less frequent dose of aflibercept (Eylea) was noninferior to the standard dose for the treatment of polypoidal choroidal vasculopathy (PCV) in patients with neovascular (“wet”) age-related macular degeneration (AMD…
Source link : https://www.medpagetoday.com/ophthalmology/generalophthalmology/119109
Author :
Publish date : 2025-12-19 18:27:00
Copyright for syndicated content belongs to the linked Source.
